Medicare-eligible patients with advanced cancers will have access to genomic tests under a national coverage determination CMS finalized March 16. The determination covers next-generation sequencing ...

“The broad capabilities of the OncoExTra assay detected therapeutically actionable and other clinically relevant genomic events that can inform clinical decision-making for patients with advanced ...

(This March 31 Health Rounds has been corrected to change ‘genetic’ to ‘genomic’ in the headline and the first item of the newsletter) April 1 (Reuters) - Advanced genomic testing could help erase ...

A Bangalore woman's advanced ovarian cancer treatment transformed after genetic testing revealed a DNA repair deficiency, not ...

For the more than 300,000 women diagnosed with breast cancer each year, one of the biggest challenges is uncertainty around treatment options. Treatment isn’t one-size-fits-all and often comes with ...

A genomic test for successfully predicting whether cancer will resist common types of chemotherapy has been developed. Cancer Research UK (CRUK) funded scientists at the University of Cambridge (UK), ...

Across all cancer types, less than 50% of patients underwent biomarker testing before first-line treatment. Many patients with advanced cancer do not receive guideline-recommended biomarker testing ...

Lung cancer affects non-smokers, with 25% of patients having never smoked, highlighting the need for awareness of persistent symptoms and environmental risk factors. Genetic testing is essential for ...

Diane Davis thought a diagnosis of advanced ovarian cancer was the answer she had been looking for. For months, she had been sick. Antibiotics were no help. When she went to the emergency room, a CT ...

NICE, France — Advanced genomic testing could help erase significant disparities in breast cancer survival rates between white and Black patients, new research has found. Currently, Black women in the ...